{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:16:34Z","timestamp":1793301394309,"version":"4.5.0"},"reference-count":216,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2025,2,11]]},"abstract":"\n Importance<\/jats:title>\n Fragility fractures result in significant morbidity.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To review evidence on osteoporosis screening to inform the US Preventive Services Task Force.<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n PubMed, Embase, Cochrane Library, and trial registries through January 9, 2024; references, experts, and literature surveillance through July 31, 2024.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n Randomized clinical trials (RCTs) and systematic reviews of screening; pharmacotherapy studies for primary osteoporosis; predictive and diagnostic accuracy studies.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n Two reviewers assessed titles\/abstracts, full-text articles, study quality, and extracted data; when at least 2 similar studies were available, meta-analyses were conducted.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Hip, clinical vertebral, major osteoporotic, and total fractures; mortality; harms; accuracy.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Three RCTs and 3 systematic reviews reported benefits of screening in older, higher-risk women. Two RCTs used 2-stage screening: Fracture Risk Assessment Tool estimate with bone mineral density (BMD) testing if risk threshold exceeded. One RCT used BMD plus additional tests. Screening was associated with reduced hip (pooled relative risk [RR], 0.83 [95% CI, 0.73-0.93]; 3 RCTs; 42\u202f009 participants) and major osteoporotic fracture (pooled RR, 0.94 [95% CI, 0.88-0.99]; 3 RCTs; 42\u202f009 participants) compared with usual care. Corresponding absolute risk differences were 5 to 6 fewer fractures per 1000 participants screened. The discriminative accuracy of risk assessment instruments to predict fracture or identify osteoporosis varied by instrument and fracture type; most had an area under the curve between 0.60 and 0.80 to predict major osteoporotic fracture, hip fracture, or both. Calibration outcomes were limited. Compared with placebo, bisphosphonates (pooled RR, 0.67 [95% CI, 0.45-1.00]; 6 RCTs; 12\u202f055 participants) and denosumab (RR, 0.60 [95% CI, 0.37-0.97] from the largest RCT [7808 participants]) were associated with reduced hip fractures. Compared with placebo, no statistically significant associations were observed for adverse events.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Screening in higher-risk women 65 years or older was associated with a small absolute risk reduction in hip and major fractures compared with usual care. No evidence evaluated screening with BMD alone or screening in men or younger women. Risk assessment instruments, BMD alone, or both have poor to modest discrimination for predicting fracture. Osteoporosis treatment with bisphosphonates or denosumab over several years was associated with fracture reductions and no meaningful increase in adverse events.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jama.2024.21653","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T11:01:31Z","timestamp":1736852491000},"page":"509","source":"Crossref","is-referenced-by-count":49,"title":["Screening for Osteoporosis to Prevent Fractures"],"prefix":"10.1001","volume":"333","author":[{"given":"Leila C.","family":"Kahwati","sequence":"first","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center"},{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Kistler","sequence":"additional","affiliation":[{"name":"Division of Geriatric Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Booth","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center"},{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nila","family":"Sathe","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center"},{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel D\u2019Amico","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Ohio State University College of Medicine, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebiere","family":"Okah","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta C.","family":"Wines","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center"},{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Viswanathan","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center"},{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"24","key":"jus240010r1","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for osteoporosis to prevent fractures: US Preventive Services Task Force recommendation statement.","volume":"319","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"issue":"9","key":"jus240010r6","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s00198-012-1964-3","article-title":"A systematic review of hip fracture incidence and probability of fracture worldwide.","volume":"23","author":"Kanis","year":"2012","journal-title":"Osteoporos Int"},{"key":"jus240010r7","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"jus240010r8","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"8","key":"jus240010r9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"1","key":"jus240010r10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies.","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"issue":"1","key":"jus240010r11","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration.","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"},{"key":"jus240010r12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jclinepi.2021.06.017","article-title":"Large-scale validation of the Prediction Model Risk of Bias Assessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination.","volume":"138","author":"Venema","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"jus240010r13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jclinepi.2015.06.005","article-title":"ROBIS: a new tool to assess risk of bias in systematic reviews was developed.","volume":"69","author":"Whiting","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"jus240010r14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"11","key":"jus240010r16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"7414","key":"jus240010r17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"11","key":"jus240010r20","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jclinepi.2014.11.023","article-title":"Grading the strength of a body of evidence when assessing health care interventions: an EPC update.","volume":"68","author":"Berkman","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"jus240010r21","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00198-019-04934-7","article-title":"Use of antiosteoporotic medication in the Danish ROSE population-based screening study.","volume":"30","author":"H\u00f8iberg","year":"2019","journal-title":"Osteoporos Int"},{"issue":"12","key":"jus240010r22","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1007\/s00198-017-4205-y","article-title":"Non-participation in systematic screening for osteoporosis\u2014the ROSE trial.","volume":"28","author":"Rothmann","year":"2017","journal-title":"Osteoporos Int"},{"issue":"3","key":"jus240010r23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00198-017-4326-3","article-title":"Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.","volume":"29","author":"Rubin","year":"2018","journal-title":"Osteoporos Int"},{"issue":"2","key":"jus240010r24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00223-014-9950-8","article-title":"The risk-stratified osteoporosis strategy evaluation study (ROSE): a randomized prospective population-based study: design and baseline characteristics.","volume":"96","author":"Rubin","year":"2015","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"jus240010r25","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/jbmr.3411","article-title":"Management of patients with high baseline hip fracture risk by FRAX reduces hip fractures\u2014a post hoc analysis of the SCOOP study.","volume":"33","author":"McCloskey","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"1","key":"jus240010r26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00198-019-05142-z","article-title":"Systematic screening using FRAX leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial.","volume":"31","author":"Parsons","year":"2020","journal-title":"Osteoporos Int"},{"issue":"10122","key":"jus240010r27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","article-title":"Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial.","volume":"391","author":"Shepstone","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"jus240010r28","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00198-011-1876-7","article-title":"A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study.","volume":"23","author":"Shepstone","year":"2012","journal-title":"Osteoporos Int"},{"issue":"1","key":"jus240010r29","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12891-017-1783-y","article-title":"Design of the SALT Osteoporosis Study: a randomised pragmatic trial to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older.","volume":"18","author":"Elders","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"jus240010r30","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/jbmr.3815","article-title":"The effect of a screening and treatment program for the prevention of fractures in older women: a randomized pragmatic trial.","volume":"34","author":"Merlijn","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"5","key":"jus240010r31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00198-022-06659-6","article-title":"The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review.","volume":"34","author":"Auais","year":"2023","journal-title":"Osteoporos Int"},{"issue":"1","key":"jus240010r32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13643-023-02181-w","article-title":"Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.","volume":"12","author":"Gates","year":"2023","journal-title":"Syst Rev"},{"issue":"1","key":"jus240010r33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13643-019-1094-5","article-title":"Screening to prevent fragility fractures among adults 40 years and older in primary care: protocol for a systematic review.","volume":"8","author":"Gates","year":"2019","journal-title":"Syst Rev"},{"issue":"2","key":"jus240010r34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00198-019-05226-w","article-title":"Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis.","volume":"31","author":"Merlijn","year":"2020","journal-title":"Osteoporos Int"},{"issue":"12","key":"jus240010r35","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1210\/jc.2014-2332","article-title":"Comparison of fracture risk prediction by the US Preventive Services Task Force strategy and two alternative strategies in women 50-64 years old in the Women\u2019s Health Initiative.","volume":"99","author":"Crandall","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"jus240010r36","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00198-012-2215-3","article-title":"Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study.","volume":"24","author":"Ettinger","year":"2013","journal-title":"Osteoporos Int"},{"issue":"2","key":"jus240010r37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jocd.2012.05.007","article-title":"Validation of the FRAX predictive model for major osteoporotic fracture in a historical cohort of Spanish women.","volume":"16","author":"Teb\u00e9 Cordom\u00ed","year":"2013","journal-title":"J Clin Densitom"},{"issue":"3","key":"jus240010r38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jocd.2012.01.011","article-title":"Validation of FRC, a fracture risk assessment tool, in a cohort of older men: the Osteoporotic Fractures in Men (MrOS) Study.","volume":"15","author":"Ettinger","year":"2012","journal-title":"J Clin Densitom"},{"key":"jus240010r39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3427","article-title":"Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study.","volume":"344","author":"Hippisley-Cox","year":"2012","journal-title":"BMJ"},{"issue":"1","key":"jus240010r40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.bone.2011.11.006","article-title":"Probability of fractures predicted by FRAX and observed incidence in the Spanish ECOSAP Study cohort.","volume":"50","author":"Gonz\u00e1lez-Mac\u00edas","year":"2012","journal-title":"Bone"},{"issue":"3","key":"jus240010r41","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00198-011-1647-5","article-title":"Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women.","volume":"23","author":"Cheung","year":"2012","journal-title":"Osteoporos Int"},{"issue":"12","key":"jus240010r42","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1007\/s00198-011-1537-x","article-title":"Fracture risk prediction using FRAX: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.","volume":"22","author":"Tamaki","year":"2011","journal-title":"Osteoporos Int"},{"issue":"22","key":"jus240010r43","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1001\/archinternmed.2009.404","article-title":"A comparison of prediction models for fractures in older women: is more better?","volume":"169","author":"Ensrud","year":"2009","journal-title":"Arch Intern Med"},{"key":"jus240010r44","doi-asserted-by":"publisher","first-page":"b4229","DOI":"10.1136\/bmj.b4229","article-title":"Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores.","volume":"339","author":"Hippisley-Cox","year":"2009","journal-title":"BMJ"},{"issue":"3","key":"jus240010r45","first-page":"188","article-title":"Fracture risk tool validation in an integrated healthcare delivery system.","volume":"17","author":"Lo","year":"2011","journal-title":"Am J Manag Care"},{"issue":"3","key":"jus240010r46","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00198-010-1465-1","article-title":"Fracture prediction and calibration of a Canadian FRAX tool: a population-based report from CaMos.","volume":"22","author":"Fraser","year":"2011","journal-title":"Osteoporos Int"},{"issue":"6","key":"jus240010r47","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.bone.2010.08.019","article-title":"The Fracture and Immobilization Score (FRISC) for risk assessment of osteoporotic fracture and immobilization in postmenopausal women\u2014a joint analysis of the Nagano, Miyama, and Taiji cohorts.","volume":"47","author":"Tanaka","year":"2010","journal-title":"Bone"},{"issue":"11","key":"jus240010r48","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1002\/jbmr.123","article-title":"Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.","volume":"25","author":"Leslie","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"1","key":"jus240010r49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00198-013-2525-0","article-title":"FRAX provides robust fracture prediction regardless of socioeconomic status.","volume":"25","author":"Brennan","year":"2014","journal-title":"Osteoporos Int"},{"issue":"1","key":"jus240010r50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/jbmr.1729","article-title":"Predictive value of FRAX for fracture in obese older women.","volume":"28","author":"Premaor","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"2","key":"jus240010r51","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1503\/cmaj.100458","article-title":"Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture.","volume":"183","author":"Langsetmo","year":"2011","journal-title":"CMAJ"},{"issue":"4","key":"jus240010r52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jocd.2011.06.006","article-title":"Methods for assessing fracture risk prediction models: experience with FRAX in a large integrated health care delivery system.","volume":"14","author":"Pressman","year":"2011","journal-title":"J Clin Densitom"},{"issue":"3","key":"jus240010r53","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00198-008-0688-x","article-title":"Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years.","volume":"20","author":"Morin","year":"2009","journal-title":"Osteoporos Int"},{"issue":"2","key":"jus240010r54","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/jbmr.215","article-title":"Evaluation of the FRAX and Garvan fracture risk calculators in older women.","volume":"26","author":"Bolland","year":"2011","journal-title":"J Bone Miner Res"},{"key":"jus240010r55","doi-asserted-by":"publisher","first-page":"d3651","DOI":"10.1136\/bmj.d3651","article-title":"Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.","volume":"342","author":"Collins","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"jus240010r56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.medcli.2013.11.014","article-title":"FRAX thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population.","volume":"144","author":"Azagra","year":"2015","journal-title":"Med Clin (Barc)"},{"key":"jus240010r57","doi-asserted-by":"publisher","first-page":"i6755","DOI":"10.1136\/bmj.i6755","article-title":"External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population-based electronic health records: retrospective cohort study.","volume":"356","author":"Dagan","year":"2017","journal-title":"BMJ"},{"issue":"12","key":"jus240010r58","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1136\/annrheumdis-2015-208958","article-title":"Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density.","volume":"75","author":"Klop","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"jus240010r59","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/jbmr.3636","article-title":"A comparison of US and Canadian osteoporosis screening and treatment strategies in postmenopausal women.","volume":"34","author":"Crandall","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"8","key":"jus240010r60","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/jbmr.3717","article-title":"Performance of FRAX and FRAX-based treatment thresholds in women aged 40 years and older: the Manitoba BMD registry.","volume":"34","author":"Crandall","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"2","key":"jus240010r61","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11606-018-4696-z","article-title":"Predicting fracture risk in younger postmenopausal women: comparison of the Garvan and FRAX risk calculators in the Women\u2019s Health Initiative Study.","volume":"34","author":"Crandall","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"1","key":"jus240010r62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/aje\/kwx128","article-title":"Fracture risk assessment with FRAX using real-world data in a population-based cohort from Israel.","volume":"187","author":"Goldshtein","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"1","key":"jus240010r63","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11657-017-0389-1","article-title":"Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS study.","volume":"12","author":"Gourlay","year":"2017","journal-title":"Arch Osteoporos"},{"issue":"9","key":"jus240010r64","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s00198-016-3613-8","article-title":"Direct comparison of FRAX(R) and a simplified fracture risk assessment tool in routine clinical practice: a registry-based cohort study.","volume":"27","author":"Leslie","year":"2016","journal-title":"Osteoporos Int"},{"key":"jus240010r65","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12891-016-1096-6","article-title":"Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.","volume":"17","author":"Azagra","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"jus240010r66","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2337\/dc18-1486","article-title":"Development and validation of a simple hip fracture risk prediction tool for type 2 diabetes: the Fremantle Diabetes Study phase I.","volume":"42","author":"Davis","year":"2019","journal-title":"Diabetes Care"},{"key":"jus240010r67","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.maturitas.2015.10.002","article-title":"Fracture experience among participants from the FROCAT study: what thresholding is appropriate using the FRAX tool?","volume":"83","author":"Azagra","year":"2016","journal-title":"Maturitas"},{"issue":"3","key":"jus240010r68","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00198-018-4415-y","article-title":"Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.","volume":"29","author":"Leslie","year":"2018","journal-title":"Osteoporos Int"},{"issue":"12","key":"jus240010r69","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10239","article-title":"Do additional clinical risk factors improve the performance of Fracture Risk Assessment Tool (FRAX) among postmenopausal women? findings from the Women\u2019s Health Initiative observational study and clinical trials.","volume":"3","author":"Crandall","year":"2019","journal-title":"JBMR Plus"},{"issue":"5","key":"jus240010r70","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/jbmr.3924","article-title":"Deterioration of cortical and trabecular microstructure identifies women with osteopenia or normal bone mineral density at imminent and long-term risk for fragility fracture: a prospective study.","volume":"35","author":"Chapurlat","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"2","key":"jus240010r71","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000509","article-title":"Do we need bone mineral density to estimate osteoporotic fracture risk? a 10-year prospective multicentre validation study.","volume":"3","author":"Marques","year":"2017","journal-title":"RMD Open"},{"issue":"6","key":"jus240010r72","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/jbmr.3977","article-title":"Comparison of fracture prediction tools in individuals without and with early chronic kidney disease: a population-based analysis of CARTaGENE.","volume":"35","author":"Desbiens","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"1","key":"jus240010r73","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13073-021-00838-6","article-title":"Improved prediction of fracture risk leveraging a genome-wide polygenic risk score.","volume":"13","author":"Lu","year":"2021","journal-title":"Genome Med"},{"issue":"8","key":"jus240010r74","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005809","article-title":"The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study.","volume":"4","author":"Hippisley-Cox","year":"2014","journal-title":"BMJ Open"},{"issue":"9","key":"jus240010r75","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10532","article-title":"Independent external validation of FRAX and Garvan fracture risk calculators: a sub-study of the FRISBEE cohort.","volume":"5","author":"Baleanu","year":"2021","journal-title":"JBMR Plus"},{"issue":"7","key":"jus240010r76","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00198-022-06349-3","article-title":"FREM predicts 10-year incident fracture risk independent of FRAX probability: a registry-based cohort study.","volume":"33","author":"Leslie","year":"2022","journal-title":"Osteoporos Int"},{"issue":"1","key":"jus240010r77","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00198-021-06165-1","article-title":"Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM).","volume":"33","author":"M\u00f6ller","year":"2022","journal-title":"Osteoporos Int"},{"key":"jus240010r78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116469","article-title":"Development and external validation of a 1- and 5-year fracture prediction tool based on electronic medical records data: the EPIC risk algorithm.","volume":"162","author":"Teb\u00e9","year":"2022","journal-title":"Bone"},{"issue":"9","key":"jus240010r79","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/jcm11092409","article-title":"Predictive performance of the FRAX tool calibrated for Spain vs. an age and sex model: prospective cohort study with 9082 women and men followed for up to 8 years.","volume":"11","author":"Garc\u00eda-Sempere","year":"2022","journal-title":"J Clin Med"},{"issue":"7","key":"jus240010r80","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/jamainternmed.2023.1253","article-title":"Race and ethnicity and fracture prediction among younger postmenopausal women in the Women\u2019s Health Initiative Study.","volume":"183","author":"Crandall","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"16","key":"jus240010r81","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1007\/s11606-023-08347-5","article-title":"Electronic health records (EHRs) can identify patients at high risk of fracture but require substantial race adjustments to currently available fracture risk calculators.","volume":"38","author":"Jain","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"1","key":"jus240010r82","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11657-023-01346-3","article-title":"Optimal fracture prediction thresholds for therapy onset, established from FRAX and Garvan algorithms: a longitudinal observation of the population representative female cohort from the RAC-OST-POL Study.","volume":"18","author":"Pluskiewicz","year":"2023","journal-title":"Arch Osteoporos"},{"issue":"1","key":"jus240010r83","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s12891-023-06670-w","article-title":"Predictive capacity of FRAX in a spanish region with a hip fracture rate close to the national mean.","volume":"24","author":"Zwart","year":"2023","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"jus240010r84","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-207907","article-title":"The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis.","volume":"74","author":"Marques","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"jus240010r85","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00198-019-04919-6","article-title":"Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression.","volume":"30","author":"Beaudoin","year":"2019","journal-title":"Osteoporos Int"},{"key":"jus240010r86","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bone.2017.02.008","article-title":"Diagnostic accuracy of FRAX in predicting the 10-year risk of osteoporotic fractures using the USA treatment thresholds: a systematic review and meta-analysis.","volume":"99","author":"Jiang","year":"2017","journal-title":"Bone"},{"issue":"4","key":"jus240010r87","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.14336\/AD.2021.1206","article-title":"Prediction Models for osteoporotic fractures risk: a systematic review and critical appraisal.","volume":"13","author":"Sun","year":"2022","journal-title":"Aging Dis"},{"issue":"11","key":"jus240010r88","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s40618-023-02082-8","article-title":"A systematic review on the performance of fracture risk assessment tools: FRAX, DeFRA, FRA-HS.","volume":"46","author":"Adami","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"jus240010r89","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00198-011-1634-x","article-title":"Predictive values of calcaneal quantitative ultrasound and dual energy X ray absorptiometry for non-vertebral fracture in older men: results from the MrOS study (Hong Kong).","volume":"23","author":"Kwok","year":"2012","journal-title":"Osteoporos Int"},{"issue":"11","key":"jus240010r90","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1002\/jbmr.499","article-title":"Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.","volume":"26","author":"Hans","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"1","key":"jus240010r91","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00223-014-9860-9","article-title":"Evaluation of the FRAX model for hip fracture predictions in the population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE).","volume":"95","author":"Sund","year":"2014","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"jus240010r92","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1007\/s00198-004-1717-z","article-title":"Bone mineral density-independent association of quantitative ultrasound measurements and fracture risk in women.","volume":"15","author":"Nguyen","year":"2004","journal-title":"Osteoporos Int"},{"issue":"20","key":"jus240010r93","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1001\/jama.298.20.2389","article-title":"Factors associated with 5-year risk of hip fracture in postmenopausal women.","volume":"298","author":"Robbins","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"jus240010r94","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1210\/jc.2012-3118","article-title":"TBS (trabecular bone score) and diabetes-related fracture risk.","volume":"98","author":"Leslie","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"jus240010r95","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/jbmr.106","article-title":"The FRAX tool in French women: how well does it describe the real incidence of fracture in the OFELY cohort?","volume":"25","author":"Sornay-Rendu","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"5","key":"jus240010r96","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/jbmr.12","article-title":"Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.","volume":"25","author":"Tr\u00e9mollieres","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"3","key":"jus240010r97","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1359\/JBMR.051205","article-title":"Long-term fracture prediction by DXA and QUS: a 10-year prospective study.","volume":"21","author":"Stewart","year":"2006","journal-title":"J Bone Miner Res"},{"key":"jus240010r98","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bone.2018.06.004","article-title":"Fracture incidence and secular trends between 1989 and 2013 in a population based cohort: the Rotterdam Study.","volume":"114","author":"Trajanoska","year":"2018","journal-title":"Bone"},{"issue":"2","key":"jus240010r99","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/jbmr.3595","article-title":"Adding lateral spine imaging for vertebral fractures to densitometric screening: improving ascertainment of patients at high risk of incident osteoporotic fractures.","volume":"34","author":"Prince","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"3","key":"jus240010r100","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/jbmr.3194","article-title":"The ability of a single BMD and fracture history assessment to predict fracture over 25 years in postmenopausal women: the study of osteoporotic fractures.","volume":"33","author":"Black","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"11","key":"jus240010r101","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00198-021-06013-2","article-title":"Predictive ability of novel volumetric and geometric indices derived from dual-energy x-ray absorptiometric images of the proximal femur for hip fracture compared with conventional areal bone mineral density: the Japanese Population-based Osteoporosis (JPOS) cohort study.","volume":"32","author":"Iki","year":"2021","journal-title":"Osteoporos Int"},{"issue":"3","key":"jus240010r102","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00198-021-06252-3","article-title":"Predictive performance of the Garvan Fracture Risk Calculator: a registry-based cohort study.","volume":"33","author":"Agarwal","year":"2022","journal-title":"Osteoporos Int"},{"issue":"7","key":"jus240010r103","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/jbmr.2174","article-title":"Osteoporosis screening in postmenopausal women 50 to 64 years old: comparison of US Preventive Services Task Force strategy and two traditional strategies in the Women\u2019s Health Initiative.","volume":"29","author":"Crandall","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"3","key":"jus240010r104","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/jgs.12696","article-title":"FRAX without bone mineral density versus osteoporosis self-assessment screening tool as predictors of osteoporosis in primary screening of individuals aged 70 and older.","volume":"62","author":"Pang","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"jus240010r105","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3122\/jabfm.2013.04.120182","article-title":"Validation of the Male Osteoporosis Risk Estimation Score (MORES) in a primary care setting.","volume":"26","author":"Cass","year":"2013","journal-title":"J Am Board Fam Med"},{"issue":"1","key":"jus240010r106","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jocd.2013.02.004","article-title":"Validation of the osteoporosis self-assessment tool in US male veterans.","volume":"17","author":"Steuart Richards","year":"2014","journal-title":"J Clin Densitom"},{"issue":"5","key":"jus240010r107","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00223-013-9699-5","article-title":"Prevalence of postmenopausal osteoporosis in Italy and validation of decision rules for referring women for bone densitometry.","volume":"92","author":"D\u2019Amelio","year":"2013","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"jus240010r108","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jocd.2013.01.004","article-title":"Selection of women aged 50-64 yr for bone density measurement.","volume":"16","author":"Leslie","year":"2013","journal-title":"J Clin Densitom"},{"issue":"6","key":"jus240010r109","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00198-009-1036-5","article-title":"Selecting men for bone densitometry: performance of osteoporosis risk assessment tools in Portuguese men.","volume":"21","author":"Machado","year":"2010","journal-title":"Osteoporos Int"},{"issue":"1","key":"jus240010r110","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00223-013-9728-4","article-title":"Reducing the need for central dual-energy x-ray absorptiometry in postmenopausal women: efficacy of a clinical algorithm including peripheral densitometry.","volume":"93","author":"Jim\u00e9nez-N\u00fa\u00f1ez","year":"2013","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"jus240010r111","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00774-013-0426-0","article-title":"Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women.","volume":"31","author":"Oh","year":"2013","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"jus240010r112","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3349\/ymj.2016.57.1.187","article-title":"Development and validation of osteoporosis risk-assessment model for Korean men.","volume":"57","author":"Oh","year":"2016","journal-title":"Yonsei Med J"},{"issue":"6","key":"jus240010r113","doi-asserted-by":"publisher","first-page":"346","DOI":"10.4082\/kjfm.2016.37.6.346","article-title":"Evaluation of the predictive index for osteoporosis as a clinical tool to identify the risk of osteoporosis in Korean men by using the Korea National Health and Nutrition Examination Survey data.","volume":"37","author":"Moon","year":"2016","journal-title":"Korean J Fam Med"},{"issue":"2","key":"jus240010r114","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jocd.2015.02.006","article-title":"Discriminatory performance of the calcaneal quantitative ultrasound and osteoporosis self-assessment tool to select older women for dual-energy x-ray absorptiometry.","volume":"18","author":"McLeod","year":"2015","journal-title":"J Clin Densitom"},{"issue":"1","key":"jus240010r115","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.286.1.57","article-title":"Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry.","volume":"286","author":"Cadarette","year":"2001","journal-title":"JAMA"},{"issue":"8","key":"jus240010r116","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s00198-005-0051-4","article-title":"Validation of various osteoporosis risk indices in elderly Chinese females in Singapore.","volume":"17","author":"Chan","year":"2006","journal-title":"Osteoporos Int"},{"issue":"12","key":"jus240010r117","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00198-005-1864-x","article-title":"Comparison of questionnaire and quantitative ultrasound techniques as screening tools for DXA.","volume":"16","author":"Cook","year":"2005","journal-title":"Osteoporos Int"},{"issue":"8","key":"jus240010r118","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00198-004-1775-2","article-title":"Performance of osteoporosis risk assessment tools in postmenopausal women aged 45-64 years.","volume":"16","author":"Gourlay","year":"2005","journal-title":"Osteoporos Int"},{"issue":"1","key":"jus240010r119","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/qjmed\/hch002","article-title":"Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium.","volume":"97","author":"Richy","year":"2004","journal-title":"QJM"},{"issue":"4","key":"jus240010r120","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S8756-3282(01)00583-X","article-title":"Evaluation of the Simple Calculated Osteoporosis Risk Estimation (SCORE) in a sample of white women from Belgium.","volume":"29","author":"Ben Sedrine","year":"2001","journal-title":"Bone"},{"issue":"7","key":"jus240010r121","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00198-004-1778-z","article-title":"Development of a clinical assessment tool in identifying Asian men with low bone mineral density and comparison of its usefulness to quantitative bone ultrasound.","volume":"16","author":"Kung","year":"2005","journal-title":"Osteoporos Int"},{"issue":"9","key":"jus240010r122","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s00198-003-1428-x","article-title":"Comparison of a simple clinical risk index and quantitative bone ultrasound for identifying women at increased risk of osteoporosis.","volume":"14","author":"Kung","year":"2003","journal-title":"Osteoporos Int"},{"issue":"6","key":"jus240010r123","first-page":"1307","article-title":"Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit.","volume":"34","author":"Mart\u00ednez-Aguil\u00e0","year":"2007","journal-title":"J Rheumatol"},{"issue":"3","key":"jus240010r124","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1385\/JCD:6:3:247","article-title":"Korean experience with the OSTA risk index for osteoporosis: a validation study.","volume":"6","author":"Park","year":"2003","journal-title":"J Clin Densitom"},{"issue":"3","key":"jus240010r125","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jocd.2007.03.001","article-title":"Validation of a novel risk estimation tool for predicting low bone density in Caucasian and African American men veterans.","volume":"10","author":"Zimering","year":"2007","journal-title":"J Clin Densitom"},{"issue":"4","key":"jus240010r126","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00223-005-0302-6","article-title":"Application of a triage approach to peripheral bone densitometry reduces the requirement for central DXA but is not cost effective.","volume":"79","author":"Harrison","year":"2006","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"jus240010r127","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s00198-005-0034-5","article-title":"Utility of screening tools for the prediction of low bone mass in African American men.","volume":"17","author":"Sinnott","year":"2006","journal-title":"Osteoporos Int"},{"issue":"4","key":"jus240010r128","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00198-015-3026-0","article-title":"US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.","volume":"26","author":"Bansal","year":"2015","journal-title":"Osteoporos Int"},{"issue":"2","key":"jus240010r129","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3122\/jabfm.2016.02.150237","article-title":"Comparison of clinical risk tools for predicting osteoporosis in women ages 50-64.","volume":"29","author":"Pecina","year":"2016","journal-title":"J Am Board Fam Med"},{"issue":"6","key":"jus240010r130","doi-asserted-by":"publisher","first-page":"723","DOI":"10.4065\/78.6.723","article-title":"Performance of the Osteoporosis Self-assessment Screening Tool for osteoporosis in American men.","volume":"78","author":"Adler","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"jus240010r131","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/109350703322425509","article-title":"Evaluation of decision rules to identify postmenopausal women for intervention related to osteoporosis.","volume":"6","author":"Brenneman","year":"2003","journal-title":"Dis Manag"},{"issue":"5","key":"jus240010r132","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00198-003-1552-7","article-title":"The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing.","volume":"15","author":"Cadarette","year":"2004","journal-title":"Osteoporos Int"},{"issue":"6","key":"jus240010r133","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1525-1497.2006.00459.x","article-title":"Osteoporosis risk assessment and ethnicity: validation and comparison of 2 clinical risk stratification instruments.","volume":"21","author":"Cass","year":"2006","journal-title":"J Gen Intern Med"},{"issue":"2","key":"jus240010r134","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00223-004-0253-3","article-title":"Effects of lifestyle and risk factors on bone mineral density in a cohort of Italian women: suggestion for a new decision rule.","volume":"77","author":"D\u2019Amelio","year":"2005","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"jus240010r135","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archinte.165.5.530","article-title":"Use of clinical prediction rules in detecting osteoporosis in a population-based sample of postmenopausal women.","volume":"165","author":"Mauck","year":"2005","journal-title":"Arch Intern Med"},{"issue":"1","key":"jus240010r136","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00198-003-1511-3","article-title":"Limited utility of clinical indices for the prediction of symptomatic fracture risk in postmenopausal women.","volume":"15","author":"Nguyen","year":"2004","journal-title":"Osteoporos Int"},{"issue":"7","key":"jus240010r137","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s00198-004-1748-5","article-title":"Performance of four clinical screening tools to select peri- and early postmenopausal women for dual x-ray absorptiometry.","volume":"16","author":"Rud","year":"2005","journal-title":"Osteoporos Int"},{"key":"jus240010r138","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.maturitas.2015.09.009","article-title":"Osteoporosis screening in postmenopausal women aged 50-64 years: BMI alone compared with current screening tools.","volume":"83","author":"Jiang","year":"2016","journal-title":"Maturitas"},{"issue":"8","key":"jus240010r139","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00198-007-0555-1","article-title":"Clinical performance of osteoporosis risk assessment tools in women aged 67 years and older.","volume":"19","author":"Gourlay","year":"2008","journal-title":"Osteoporos Int"},{"issue":"7","key":"jus240010r140","doi-asserted-by":"publisher","first-page":"629","DOI":"10.4065\/77.7.629","article-title":"Performance of risk indices for identifying low bone density in postmenopausal women.","volume":"77","author":"Geusens","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"jus240010r141","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1370\/afm.1945","article-title":"Comparison of the Male Osteoporosis Risk Estimation Score (MORES) with FRAX in identifying men at risk for osteoporosis.","volume":"14","author":"Cass","year":"2016","journal-title":"Ann Fam Med"},{"issue":"2","key":"jus240010r142","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3122\/jabfm.2010.02.090027","article-title":"Determining risk of vertebral osteoporosis in men: validation of the male osteoporosis risk estimation score.","volume":"23","author":"Shepherd","year":"2010","journal-title":"J Am Board Fam Med"},{"issue":"20","key":"jus240010r143","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003415","article-title":"Comparisons of different screening tools for identifying fracture\/osteoporosis risk among community-dwelling older people.","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"jus240010r144","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s11606-017-4153-4","article-title":"Screening for osteoporosis in older men: operating characteristics of proposed strategies for selecting men for BMD testing.","volume":"32","author":"Diem","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"7","key":"jus240010r145","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00198-007-0553-3","article-title":"An evaluation of osteoporosis screening tools for the osteoporotic fractures in men (MrOS) study.","volume":"19","author":"Lynn","year":"2008","journal-title":"Osteoporos Int"},{"issue":"11","key":"jus240010r146","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1007\/s00198-017-4172-3","article-title":"A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis.","volume":"28","author":"Williams","year":"2017","journal-title":"Osteoporos Int"},{"issue":"4","key":"jus240010r147","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00198-017-4368-6","article-title":"FRAX calculated without BMD does not correctly identify Caucasian men with densitometric evidence of osteoporosis.","volume":"29","author":"Hamdy","year":"2018","journal-title":"Osteoporos Int"},{"key":"jus240010r148","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2019.103940","article-title":"Case finding with GARVAN fracture risk calculator in primary prevention of fragility fractures in older people.","volume":"86","author":"Inderjeeth","year":"2020","journal-title":"Arch Gerontol Geriatr"},{"issue":"6","key":"jus240010r149","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/1557988315574857","article-title":"Optimal analysis to discriminate males\u2019 osteoporosis with simple physiological indicators: a cutoff point study.","volume":"10","author":"Chang","year":"2016","journal-title":"Am J Mens Health"},{"issue":"3","key":"jus240010r150","first-page":"84","article-title":"Improving rural bone health and minimizing fracture risk in West Virginia: validation of the World Health Organization FRAX assessment tool as a phone survey for osteoporosis detection.","volume":"112","author":"Shuler","year":"2016","journal-title":"W V Med J"},{"issue":"9","key":"jus240010r151","doi-asserted-by":"publisher","first-page":"577","DOI":"10.5312\/wjo.v7.i9.577","article-title":"Risk assessment instruments for screening bone mineral density in a Mediterranean population.","volume":"7","author":"Christodoulou","year":"2016","journal-title":"World J Orthop"},{"issue":"4","key":"jus240010r152","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jocd.2021.03.003","article-title":"Utility of osteoporosis self-assessment tool as a screening tool for osteoporosis in Irish men and women: results of the DXA-HIP project.","volume":"24","author":"Erjiang","year":"2021","journal-title":"J Clin Densitom"},{"issue":"3","key":"jus240010r153","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.afos.2019.09.001","article-title":"A comparison of 6 osteoporosis risk assessment tools among postmenopausal women in Kuala Lumpur, Malaysia.","volume":"5","author":"Toh","year":"2019","journal-title":"Osteoporos Sarcopenia"},{"issue":"12","key":"jus240010r154","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1001\/jama.2013.277817","article-title":"Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture.","volume":"310","author":"Berry","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"jus240010r155","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/archinte.167.2.155","article-title":"Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures.","volume":"167","author":"Hillier","year":"2007","journal-title":"Arch Intern Med"},{"issue":"3","key":"jus240010r156","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/jbmr.3054","article-title":"Change in Trabecular Bone Score (TBS) with antiresorptive therapy does not predict fracture in women: the Manitoba BMD Cohort.","volume":"32","author":"Leslie","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"9","key":"jus240010r157","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1001\/jamainternmed.2020.2986","article-title":"Serial bone density measurement and incident fracture risk discrimination in postmenopausal women.","volume":"180","author":"Crandall","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"9","key":"jus240010r158","doi-asserted-by":"publisher","first-page":"e3877","DOI":"10.1210\/clinem\/dgac324","article-title":"Repeat bone mineral density screening measurement and fracture prediction in older men: a prospective cohort study.","volume":"107","author":"Ensrud","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"jus240010r159","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","article-title":"Fracture risk and zoledronic acid therapy in men with osteoporosis.","volume":"367","author":"Boonen","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"jus240010r160","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/archinte.163.7.789","article-title":"Alendronate prevents loss of bone density associated with discontinuation of hormone replacement therapy: a randomized controlled trial.","volume":"163","author":"Ascott-Evans","year":"2003","journal-title":"Arch Intern Med"},{"issue":"2","key":"jus240010r161","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0002-9343(99)80134-X","article-title":"Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling.","volume":"99","author":"Chesnut","year":"1995","journal-title":"Am J Med"},{"issue":"24","key":"jus240010r162","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"issue":"22","key":"jus240010r163","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis.","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"issue":"5","key":"jus240010r164","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women.","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"jus240010r165","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1210\/jcem.83.2.4586","article-title":"Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up.","volume":"83","author":"Mortensen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"jus240010r166","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/PL00004171","article-title":"Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study.","volume":"9","author":"Pols","year":"1999","journal-title":"Osteoporos Int"},{"issue":"9","key":"jus240010r167","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa011807","article-title":"Intravenous zoledronic acid in postmenopausal women with low bone mineral density.","volume":"346","author":"Reid","year":"2002","journal-title":"N Engl J Med"},{"issue":"9","key":"jus240010r168","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/j.clinthera.2007.09.017","article-title":"Effects of risedronate 5 mg\/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.","volume":"29","author":"V\u00e4lim\u00e4ki","year":"2007","journal-title":"Clin Ther"},{"issue":"10","key":"jus240010r169","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/jbmr.103","article-title":"Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial.","volume":"25","author":"Grey","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"5","key":"jus240010r170","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S8756-3282(96)00229-3","article-title":"The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study.","volume":"19","author":"Ravn","year":"1996","journal-title":"Bone"},{"issue":"10","key":"jus240010r171","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1359\/jbmr.2001.16.10.1871","article-title":"Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis.","volume":"16","author":"Riis","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"9","key":"jus240010r172","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1210\/jc.2004-1750","article-title":"Monthly oral ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot study.","volume":"90","author":"Reginster","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"jus240010r173","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1185\/030079903125002009","article-title":"Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study.","volume":"19","author":"Hosking","year":"2003","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"jus240010r174","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4065\/80.3.343","article-title":"Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of -1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial.","volume":"80","author":"Quandt","year":"2005","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"jus240010r175","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0002-9343(96)00282-3","article-title":"Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis.","volume":"101","author":"Tucci","year":"1996","journal-title":"Am J Med"},{"issue":"2","key":"jus240010r176","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/joim.12901","article-title":"Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis of a randomized controlled trial.","volume":"286","author":"Reid","year":"2019","journal-title":"J Intern Med"},{"issue":"25","key":"jus240010r177","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","article-title":"Fracture prevention with zoledronate in older women with osteopenia.","volume":"379","author":"Reid","year":"2018","journal-title":"N Engl J Med"},{"issue":"36","key":"jus240010r178","doi-asserted-by":"publisher","first-page":"E1130","DOI":"10.1503\/cmaj.161207","article-title":"Duration of antiresorptive activity of zoledronate in postmenopausal women with osteopenia: a randomized, controlled multidose trial.","volume":"189","author":"Grey","year":"2017","journal-title":"CMAJ"},{"issue":"1","key":"jus240010r179","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jbmr.4167","article-title":"Predictors of fracture in older women with osteopenic hip bone mineral density treated with zoledronate.","volume":"36","author":"Reid","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"1","key":"jus240010r180","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1210\/jc.2011-2081","article-title":"Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial.","volume":"97","author":"Grey","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"jus240010r181","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/jbmr.2009","article-title":"Duration of antiresorptive effects of low-dose zoledronate in osteopenic postmenopausal women: a randomized, placebo-controlled trial.","volume":"29","author":"Grey","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"3","key":"jus240010r182","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.bone.2008.09.011","article-title":"Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss.","volume":"44","author":"McClung","year":"2009","journal-title":"Bone"},{"issue":"6","key":"jus240010r183","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1210\/jcem.87.6.8575","article-title":"Alendronate increases bone mass and reduces bone markers in postmenopausal African-American women.","volume":"87","author":"Bell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"jus240010r184","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1210\/jcem.82.1.3682","article-title":"Dose-response relationships for alendronate treatment in osteoporotic elderly women.","volume":"82","author":"Bone","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"jus240010r185","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1210\/jc.2008-2241","article-title":"The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women.","volume":"94","author":"Grey","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"jus240010r186","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/GME.0b013e318267f909","article-title":"Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture.","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"issue":"9","key":"jus240010r187","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1210\/jc.2012-1569","article-title":"A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density.","volume":"97","author":"Orwoll","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"jus240010r188","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/jbmr.1606","article-title":"Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX.","volume":"27","author":"McCloskey","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"3","key":"jus240010r189","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00198-011-1786-8","article-title":"Dose-response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis.","volume":"23","author":"Nakamura","year":"2012","journal-title":"Osteoporos Int"},{"issue":"8","key":"jus240010r190","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis.","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"jus240010r191","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1359\/jbmr.070809","article-title":"Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD.","volume":"22","author":"Lewiecki","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"6","key":"jus240010r192","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1210\/jc.2007-2814","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.","volume":"93","author":"Bone","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"jus240010r193","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3109\/13697137.2015.1045484","article-title":"Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis.","volume":"18","author":"Palacios","year":"2015","journal-title":"Climacteric"},{"issue":"4","key":"jus240010r194","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3349\/ymj.2016.57.4.905","article-title":"Assessment of denosumab in Korean postmenopausal women with osteoporosis: randomized, double-blind, placebo-controlled trial with open-label extension.","volume":"57","author":"Koh","year":"2016","journal-title":"Yonsei Med J"},{"issue":"8","key":"jus240010r195","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.clinthera.2009.08.016","article-title":"Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.","volume":"31","author":"Adachi","year":"2009","journal-title":"Clin Ther"},{"issue":"3","key":"jus240010r196","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1543-5946(05)80019-4","article-title":"A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosis.","volume":"3","author":"Cryer","year":"2005","journal-title":"Am J Geriatr Pharmacother"},{"issue":"4","key":"jus240010r197","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/archinte.160.4.517","article-title":"Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial.","volume":"160","author":"Bauer","year":"2000","journal-title":"Arch Intern Med"},{"issue":"18","key":"jus240010r198","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJMc076132","article-title":"Alendronate and atrial fibrillation.","volume":"356","author":"Cummings","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"jus240010r199","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/8756-3282(95)00436-X","article-title":"Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis.","volume":"18","author":"Devogelaer","year":"1996","journal-title":"Bone"},{"issue":"5","key":"jus240010r200","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1185\/030079904125003548","article-title":"Upper gastrointestinal and overall tolerability of alendronate once weekly in patients with osteoporosis: results of a randomized, double-blind, placebo-controlled study.","volume":"20","author":"Eisman","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"jus240010r201","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.4065\/77.10.1044","article-title":"Tolerability of once-weekly alendronate in patients with osteoporosis: a randomized, double-blind, placebo-controlled study.","volume":"77","author":"Greenspan","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"19","key":"jus240010r202","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1001\/jama.289.19.2525","article-title":"Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.","volume":"289","author":"Greenspan","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"jus240010r203","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1210\/jcem.87.3.8325","article-title":"Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.","volume":"87","author":"Johnell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"jus240010r204","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00198-012-1947-4","article-title":"Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia\u2014a randomized placebo-controlled trial.","volume":"24","author":"Chapurlat","year":"2013","journal-title":"Osteoporos Int"},{"issue":"1","key":"jus240010r205","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1359\/jbmr.0301202","article-title":"Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.","volume":"19","author":"McClung","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"2","key":"jus240010r206","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1365-2796.2003.01174.x","article-title":"Oral weekly ibandronate prevents bone loss in postmenopausal women.","volume":"254","author":"Tank\u00f3","year":"2003","journal-title":"J Intern Med"},{"issue":"4","key":"jus240010r207","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0002-9343(97)00249-0","article-title":"Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis.","volume":"103","author":"Thi\u00e9baud","year":"1997","journal-title":"Am J Med"},{"issue":"3","key":"jus240010r208","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00198-002-1369-9","article-title":"A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group).","volume":"14","author":"Shiraki","year":"2003","journal-title":"Osteoporos Int"},{"issue":"5","key":"jus240010r209","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/AOG.0b013e3181bdce0a","article-title":"Zoledronic acid for the prevention of bone loss in postmenopausal women with low bone mass: a randomized controlled trial.","volume":"114","author":"McClung","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"1","key":"jus240010r210","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/jbmr.3860","article-title":"Effects of zoledronate on cancer, cardiac events, and mortality in osteopenic older women.","volume":"35","author":"Reid","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"1","key":"jus240010r211","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00198-011-1755-2","article-title":"Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?","volume":"23","author":"Watts","year":"2012","journal-title":"Osteoporos Int"},{"issue":"8","key":"jus240010r212","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density.","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"jus240010r213","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00223-018-0493-2","article-title":"Bisphosphonates use and risk of subtrochanteric and diaphyseal femur fractures in Korea: results from the National Claim Registry.","volume":"104","author":"Lee","year":"2019","journal-title":"Calcif Tissue Int"},{"key":"jus240010r214","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115296","article-title":"Cardiovascular and skeletal safety of zoledronic acid in osteoporosis observational, matched cohort study using Danish and Swedish health registries.","volume":"134","author":"Rubin","year":"2020","journal-title":"Bone"},{"issue":"11","key":"jus240010r215","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s00198-012-1902-4","article-title":"Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate\u2014Danish National Register Based Cohort Study.","volume":"23","author":"Pazianas","year":"2012","journal-title":"Osteoporos Int"},{"issue":"1","key":"jus240010r216","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jama.2024.8481","article-title":"Interventions to prevent falls in community-dwelling older adults: US Preventive Services Task Force recommendation statement.","volume":"332","author":"US Preventive Services Task Force","year":"2024","journal-title":"JAMA"},{"key":"jus240010r3","author":"Kahwati","year":"2025"},{"key":"jus240010r4","author":"Viswanathan","year":"2018"},{"key":"jus240010r18","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Deeks","year":"2019"},{"key":"jus240010r2","unstructured":"US Preventive Services Task Force. US Preventive Services Task Force Procedure Manual. Published 2021. Accessed November 13, 2024. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/about-uspstf\/methods-and-processes\/procedure-manual"},{"key":"jus240010r5","unstructured":"United Nations Development Programme. Human Development Index (HDI) ranking. Published 2020. Accessed November 14, 2022. https:\/\/hdr.undp.org\/data-center\/country-insights#\/ranks"},{"key":"jus240010r15","unstructured":"Cochrane. Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons; 2022."},{"key":"jus240010r19","unstructured":"US Preventive Services Task Force. US Preventive Services Task Force Procedure Manual, Appendix XII: Summary of Evidence Table for Evidence Reviews. Published 2021. Accessed November 13, 2024. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/about-uspstf\/methods-and-processes\/procedure-manual\/procedure-manual-appendix-xii-summary-evidence-table-evidence-reviews"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2829239\/jama_kahwati_2025_us_240010_1738701756.90768.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T11:11:14Z","timestamp":1739272274000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2829239"}},"subtitle":["A Systematic Evidence Review for the US Preventive Services Task Force"],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":216,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,2,11]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.21653","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,11]]}}}